Cargando…

On demand CRISPR-mediated RNA N6-methyladenosine editing

Detalles Bibliográficos
Autores principales:	Xu, Ying, Liang, Fu-Sen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chongqing Medical University 2022
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485264/ https://www.ncbi.nlm.nih.gov/pubmed/36157499 http://dx.doi.org/10.1016/j.gendis.2022.05.019

Ejemplares similares

Inducible and reversible RNA N(6)-methyladenosine editing
por: Shi, Huaxia, et al.
Publicado: (2022)

CRISPR-mediated RNA base editing: a promising strategy to rescue deafness
por: Liu, Wenyi, et al.
Publicado: (2023)

Programmable RNA N(6)-methyladenosine editing by CRISPR-Cas9 conjugates
por: Liu, Xiao-Min, et al.
Publicado: (2019)

CRISPR-mediated genome editing of Plasmodium falciparum malaria parasites
por: Lee, Marcus CS, et al.
Publicado: (2014)

CCR5-Δ32 biology, gene editing, and warnings for the future of CRISPR-Cas9 as a human and humane gene editing tool
por: Xu, MengMeng
Publicado: (2020)

The Cpf1 CRISPR-Cas protein expands genome-editing tools
por: Fagerlund, Robert D., et al.
Publicado: (2015)

Redefining mouse transgenesis with CRISPR/Cas9 genome editing technology
por: Burgio, Gaetan
Publicado: (2018)

Membrane-destabilizing ionizable phospholipids: Novel components for organ-selective mRNA delivery and CRISPR–Cas gene editing
por: Meng, Ning, et al.
Publicado: (2021)

Promoting RNA editing by ADAR attraction
por: Danan-Gotthold, Miri, et al.
Publicado: (2017)

Editing base in mouse model
por: Wang, Haoyi
Publicado: (2017)

Understanding and repurposing CRISPR-mediated alternative splicing
por: Smith, Jordan L., et al.
Publicado: (2018)

Research highlights for issue 6: the CRISPR/Cas revolution
por: Koskella, Britt
Publicado: (2015)

Genome editing enables defense-yield balance in rice
por: Deng, Yiwen, et al.
Publicado: (2023)

Adenine base editing to mimic or correct disease mutations in rodents
por: Ren, Ruotong, et al.
Publicado: (2018)

Function and evolution of RNA N6-methyladenosine modification
por: Zhu, Zhi-Man, et al.
Publicado: (2020)

Identification of evolutionarily meaningful information within the mammalian RNA editing landscape
por: Savva, Yiannis A, et al.
Publicado: (2014)

Skeletal Editing—Nitrogen Deletion of Secondary Amines by Anomeric Amide Reagents
por: Zippel, Christoph, et al.
Publicado: (2021)

The roles of RNA N(6)-methyladenosine in esophageal cancer
por: Teng, Chuan, et al.
Publicado: (2022)

CRISPR sabotage
por: van der Oost, John, et al.
Publicado: (2015)

Epitranscriptomic editing of the RNA N6-methyladenosine modification by dCasRx conjugated methyltransferase and demethylase
por: Xia, Zhen, et al.
Publicado: (2021)

New insights into pathogen-mediated modulation of host RNA splicing
por: Gao, Chuyun, et al.
Publicado: (2022)

Role of Main RNA Methylation in Hepatocellular Carcinoma: N6-Methyladenosine, 5-Methylcytosine, and N1-Methyladenosine
por: Xu, Yating, et al.
Publicado: (2021)

N(6)-methyladenosine promotes induction of ADAR1-mediated A-to-I RNA editing to suppress aberrant antiviral innate immune responses
por: Terajima, Hideki, et al.
Publicado: (2021)

The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer
por: Hu, Xiaoge, et al.
Publicado: (2022)

N(6)‐methyladenosine (m(6)A) RNA modification in human cancer
por: Huo, Fu‐Chun, et al.
Publicado: (2020)

Editing cholesterol out of the blood
por: Abbott, Ben
Publicado: (2021)

The Potential Roles of RNA N6-Methyladenosine in Urological Tumors
por: Li, Yang, et al.
Publicado: (2020)

Advantages of using the CRISPR/Cas9 system of genome editing to investigate male reproductive mechanisms using mouse models
por: Young, Samantha AM, et al.
Publicado: (2015)

N6-Methyladenosine RNA Methylation in Cardiovascular Diseases
por: Liu, Chi, et al.
Publicado: (2022)

RNA N(6)-Methyladenosine Modifications and the Immune Response
por: Wang, Ya-Nan, et al.
Publicado: (2020)

The role of RNA N(6)-methyladenosine methyltransferase in cancers
por: Huang, Jiali, et al.
Publicado: (2021)

Prime time for base editing in the mitochondria
por: Morgan, Michael A., et al.
Publicado: (2022)

METTL3-mediated mRNA N(6)-methyladenosine is required for oocyte and follicle development in mice
por: Mu, Haiyuan, et al.
Publicado: (2021)

Boosting plant immunity with CRISPR/Cas
por: Chaparro-Garcia, Angela, et al.
Publicado: (2015)

The continuously evolving CRISPR barcoding toolbox
por: Gaj, Thomas, et al.
Publicado: (2018)

CRISPR enables directed evolution in plants
por: Zhang, Yingxiao, et al.
Publicado: (2019)

N(6)-Methyladenosine in Nuclear RNA is a Major Substrate of the Obesity-Associated FTO
por: Jia, Guifang, et al.
Publicado: (2011)

Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer
por: Liang, Zhixian, et al.
Publicado: (2020)

A CRISPR way to engineer the human genome
por: Ramalingam, Sivaprakash, et al.
Publicado: (2013)

A CRISPR design for next-generation antimicrobials
por: Beisel, Chase L, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nqndn3ii76ro20kemcod8uki94